Alvotech (ALVO) vs Mineralys Therapeutics, Inc. (MLYS)

A side-by-side comparison of Alvotech and Mineralys Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Alvotech logo
ALVO
Alvotech
$2.05B
$6.08HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Mineralys Therapeutics, Inc. logo
MLYS
Mineralys Therapeutics, Inc.
$1.98B
$22.45HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — ALVO vs MLYS

growth of $100 · dividends reinvested · last 4y
ALVO -54.4% (-17.8%/yr)MLYS +26.4% (+6.0%/yr)MLYS compounded faster over this window
50100150200250Start $100202420252026$46$126
ALVO MLYS

ALVO vs MLYS: by the numbers

  • •ALVO is the larger company ($2.05B vs $1.98B market cap).
  • •Both run net losses; MLYS's is the smaller (0.00% vs -36.51% net margin).

Metrics side by side

Valuation

MetricALVOMLYS
P/S ratio4.18N/A
P/B ratioN/A3.59
EV / EBITDA41.69N/A

Profitability

MetricALVOMLYS
Gross margin60.45%0.00%
Operating margin9.62%0.00%
Net margin-36.51%0.00%
ROEN/A-63.45%
ROIC3.61%-57.17%

Growth (annualized)

MetricALVOMLYS
Revenue CAGR (5Y)69.03%N/A

Go deeper

Full ALVO analysisFull MLYS analysisInteractive comparison tool

Dig into the metrics

Alvotech ROEMineralys Therapeutics ROEAlvotech operating marginMineralys Therapeutics operating marginAlvotech revenue growthMineralys Therapeutics revenue growthAlvotech free cash flowMineralys Therapeutics free cash flow

Alvotech & Mineralys Therapeutics appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.